Standout Papers

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hep... 1998 2026 2007 2016 2.8k
  1. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C (1998)
    John G. McHutchison, Stuart C. Gordon et al. New England Journal of Medicine
  2. Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States (2002)
    George Ostapowicz, Robert J. Fontana et al. Annals of Internal Medicine
  3. Acetaminophen‐induced acute liver failure (2005)
    Anne M. Larson, Julie Polson et al. Hepatology
  4. Drug-Induced Hepatotoxicity (2003)
    William M. Lee New England Journal of Medicine
  5. Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection (2009)
    John G. McHutchison, Eric Lawitz et al. New England Journal of Medicine
  6. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster (2006)
    Michael Dews, Duonan Yu et al. Nature Genetics
  7. Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C (2002)
    John G. McHutchison, Michael P. Manns et al. Gastroenterology
  8. AASLD position paper (2005)
    Julie Polson, William M. Lee Hepatology
  9. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury (2014)
    Naga Chalasani, Paul H. Hayashi et al. The American Journal of Gastroenterology
  10. Acute liver failure (2019)
    R. Todd Stravitz, William M. Lee The Lancet
  11. Drug-Induced Acute Liver Failure (2010)
    Adrian Reuben, David Koch et al. Hepatology
  12. Acute liver failure (2008)
    William M. Lee, Robert H. Squires et al. Hepatology
  13. Acute Liver Failure (1993)
    William M. Lee New England Journal of Medicine
  14. Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure (2009)
    William M. Lee, Linda S. Hynan et al. Gastroenterology
  15. Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away? (2017)
    William M. Lee Journal of Hepatology
  16. AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2022)
    Robert J. Fontana, Iris Liou et al. Hepatology

Immediate Impact

5 by Nobel laureates 12 from Science/Nature 98 standout
Sub-graph 1 of 14

Citing Papers

New Approaches to Chronic Hepatitis B
2023 Standout
Benchmarking Metagenomics Tools for Taxonomic Classification
2019 Standout

Works of William M. Lee being referenced

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
2021
Viral Surveillance in Serum Samples From Patients With Acute Liver Failure By Metagenomic Next-Generation Sequencing
2017

Author Peers

Author Last Decade Papers Cites
William M. Lee 18919 15796 11155 377 31.7k
Naga Chalasani 13934 25932 4979 485 35.8k
K. Rajender Reddy 27667 24323 3237 577 36.3k
Jay H. Hoofnagle 29585 29885 3716 388 42.8k
Vicente Arroyo 34615 29823 4529 512 45.3k
David E. Kleiner 17152 31134 2688 510 49.1k
Julia Wendon 11039 7821 5095 255 18.4k
Patrick S. Kamath 22808 21671 2598 419 32.8k
Herbert L. Bonkovsky 7225 7520 3479 363 19.4k
Pere Ginès 31358 26309 3841 450 37.9k
Michael Trauner 14464 17878 3573 855 37.8k

All Works

Loading papers...

Rankless by CCL
2026